Commentary Article
Profiling of Drugs for Membrane Activity Using Liposomes as an In Vitro Model System
DOI: 110.36648/2321-547X.11.4.37
Short Communication
Multifunctional Nanoparticles with Anti-inflammatory Effect for Improving Metabolic Syndromes
DOI: 110.36648/2321-547X.11.4.32
Nanotechnology in the Diagnosis of Atherosclerotic Disease
DOI: 110.36648/2321-547X.11.4.34
Phage Display Technology as a Powerful Platform for Antibody Drug Discovery
DOI: 110.36648/2321-547X.11.40
Commentary
Liposomes as Carriers of Anticancer Medicines
DOI: 110.36648/2321-547X.11.4.35
Synthesis and in Vivo Bioactivity of Lipophilic Alendronate Derivatives against Osteoporosis
DOI: 110.36648/2321-547X.11.4.33
Advances in Antibody Engineering for Rheumatic Diseases
DOI: 110.36648/2321-547X.11.4.39
Versatile and rapid microfluidics-assisted antibody discovery
DOI: 110.36648/2321-547X.11.4.38
Novel Drug Delivery System for Myocardium Targeting
DOI: 110.36648/2321-547X.11.4.31
Characterization of Iopromide-Carrying Liposomes
DOI: 110.36648/2321-547X.11.4.36
American Journal of Advanced Drug Delivery received 1671 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 